Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.370 | 5.370 | 0.000 |
Stocks | 88.510 | 88.510 | 0.000 |
Bonds | 6.590 | 6.590 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.750 | 21.169 |
Price to Book | 2.757 | 2.532 |
Price to Sales | 2.205 | 2.940 |
Price to Cash Flow | 15.252 | 12.483 |
Dividend Yield | 1.668 | 2.224 |
5 Years Earnings Growth | 15.449 | 11.690 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 97.590 | 97.348 |
Industrials | 2.410 | 0.866 |
Number of long holdings: 30
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Beijing Tiantan Bio | CNE000000WF9 | 7.61 | 21.23 | -0.24% | |
Jiangsu Hengrui | CNE0000014W7 | 7.11 | 49.98 | +2.67% | |
TREASURY COUPON BOND 2022 28 | - | 6.59 | - | - | |
China Resources Boya Bio pharmaceutical | CNE100001FF1 | 6.59 | 30.92 | -0.13% | |
Imeik | CNE100004868 | 6.36 | 207.42 | +1.55% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 6.11 | 267.55 | +0.36% | |
APT Medical | CNE100004C45 | 5.89 | 359.60 | +0.18% | |
Guangxi Liuzhou Pharm | CNE100001VR3 | 5.74 | 17.94 | -0.39% | |
Beijing Tongrentang | CNE000000R69 | 5.73 | 39.80 | +0.84% | |
Yifeng Pharmacy Chain | CNE100001TS5 | 4.63 | 22.94 | +0.22% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Harvest Emerging Industry Eq | 5.63B | -0.61 | -14.83 | 11.90 | ||
Harvest Value Selected Equity Fund | 4.83B | 13.47 | -1.27 | - | ||
Harvest U.S. Growth Equity QDII RMB | 4.1B | 24.15 | 11.89 | 14.67 | ||
Harvest Taihe Balanced Fd | 3.09B | 0.75 | -14.18 | 10.29 | ||
Harvest Smart Car Eq | 2.78B | -1.51 | -23.87 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review